Social conformism and confidence in systems as additional psychological antecedents of vaccination: a survey to explain intention for COVID-19 vaccination among healthcare and welfare sector workers, France, December 2020 to February 2021.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
04 2022
Historique:
entrez: 29 4 2022
pubmed: 30 4 2022
medline: 3 5 2022
Statut: ppublish

Résumé

BackgroundThe start of the COVID-19 vaccination campaign among French healthcare and welfare sector workers in January 2021 offered an opportunity to study psychological antecedents of vaccination in this group.AimWe explored whether knowledge and attitude items related to social conformism and confidence in systems contributed to explaining intention for COVID-19 vaccination.MethodsWe developed a knowledge and attitude questionnaire with 30 items related to five established and two hypothetical psychological antecedents of vaccination (KA-7C). The online questionnaire was distributed from 18 December 2020 to 1 February 2021 through chain-referral via professional networks, yielding a convenience sample. We used multivariable logistic regression to explore the associations of individual and grouped KA-7C items with COVID-19 vaccine intention.ResultsAmong 5,234 participants, the vaccine intention model fit (pseudo R-squared values) increased slightly but significantly from 0.62 to 0.65 when adding social conformism and confidence in systems items. Intention to vaccinate was associated with the majority opinion among family and friends (OR: 11.57; 95% confidence interval (CI): 4.51-29.67) and a positive perception of employer's encouragement to get vaccinated (vs negative; OR: 6.41; 95% CI: 3.36-12.22). The strongest association of a knowledge item was identifying the statement '

Identifiants

pubmed: 35485271
doi: 10.2807/1560-7917.ES.2022.27.17.2100617
pmc: PMC9052769
doi:

Substances chimiques

COVID-19 Vaccines 0
Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
BMJ Open. 2021 Oct 4;11(10):e055148
pubmed: 34607874
Vaccines (Basel). 2021 Mar 04;9(3):
pubmed: 33806641
Vaccines (Basel). 2021 Mar 12;9(3):
pubmed: 33808958
Soc Sci Med. 2018 Jun;207:106-116
pubmed: 29738898
Euro Surveill. 2016 Nov 24;21(47):
pubmed: 27918262
Vaccine. 2021 Jan 29;39(5):805-814
pubmed: 33419603
Vaccine. 2021 Jun 29;39(29):3916-3925
pubmed: 34088507
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713
Vaccine. 2017 May 9;35(20):2676-2684
pubmed: 28408120
Vaccine. 2006 Jan 30;24(5):644-51
pubmed: 16157423
J Pers Soc Psychol. 2006 Apr;90(4):556-77
pubmed: 16649855
Expert Rev Vaccines. 2020 Oct;19(10):937-947
pubmed: 33107353
Vaccine. 2021 Feb 12;39(7):1080-1086
pubmed: 33461833
Nat Immunol. 2019 Oct;20(10):1257-1259
pubmed: 31477920
Med Mal Infect. 2006 Mar;36(3):144-50
pubmed: 16581213
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Top Cogn Sci. 2010 Jul;2(3):528-54
pubmed: 25163875
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478623
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Vaccine. 2014 Dec 5;32(51):6986-6991
pubmed: 25454867
Hum Vaccin Immunother. 2020 May 3;16(5):1125-1131
pubmed: 31809633
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547

Auteurs

Simi Moirangthem (S)

EHESP French School of Public Health, Paris and Rennes, France.

Cyril Olivier (C)

Research Group for the Prevention of Occupational Infections in Healthcare Workers (GERES), Paris, France.

Amandine Gagneux-Brunon (A)

Chaire PreVacCI de l'Institut Presage, Université Jean Monnet Saint-Etienne, Saint-Étienne, France.
CIC-1408, Vaccinologie, INSERM, CHU St Etienne, Saint-Étienne, France.

Gérard Péllissier (G)

Research Group for the Prevention of Occupational Infections in Healthcare Workers (GERES), Paris, France.

Dominique Abiteboul (D)

Research Group for the Prevention of Occupational Infections in Healthcare Workers (GERES), Paris, France.

Isabelle Bonmarin (I)

Santé Publique France, Saint-Maurice, France.

Elisabeth Rouveix (E)

Research Group for the Prevention of Occupational Infections in Healthcare Workers (GERES), Paris, France.
Université Versailles Saint Quentin en Yvelines, APHP, CHU Ambroise Paré, Versailles, France.

Elisabeth Botelho-Nevers (E)

Chaire PreVacCI de l'Institut Presage, Université Jean Monnet Saint-Etienne, Saint-Étienne, France.
CIC-1408, Vaccinologie, INSERM, CHU St Etienne, Saint-Étienne, France.

Judith E Mueller (JE)

EHESP French School of Public Health, Paris and Rennes, France.
Institut Pasteur, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH